{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:48:22Z","timestamp":1791496102401,"version":"4.3.4"},"reference-count":100,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["COS"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Quinoline derivatives are an important class of heterocyclic compounds and possess various\napplications in synthetic organic chemistry, medicinal chemistry, material chemistry and natural\nproduct chemistry. This review article describes the different quinoline derivatives having antimalarial,\nanalgesic, anti-inflammatory, antineoplastic, antibacterial, antifungal, antiviral, anthelmintic,\nantiprotozoal, cardiovascular, CNS and other useful bioactivities. We have delineated the general\nsynthetic routes for the synthesis of many bioactive quinoline based heterocycles. In addition to\nthis, we have also discussed the crucial synthetic routes as well as their mechanistic paths for the\nformation of bioactive quinoline derivatives. The study shows that substitution at the 4 and 8-\nposition of quinoline is more crucial for bioactivity as compared to other positions.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570179420666221004143910","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T04:10:36Z","timestamp":1664943036000},"page":"606-629","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Synthetic Strategies for Quinoline Based Derivatives as Potential Bioactive\nHeterocycles"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9339-0244","authenticated-orcid":true,"given":"Shivangi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Applied Chemistry, Amity School of Engineering &amp; Technology, Amity University Madhya Pradesh,\nGwalior, Madhya Pradesh-474 005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2913-6644","authenticated-orcid":true,"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Applied Chemistry, Amity School of Engineering &amp; Technology, Amity University Madhya Pradesh,\nGwalior, Madhya Pradesh-474 005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Applied Chemistry, Amity School of Engineering &amp; Technology, Amity University Madhya Pradesh,\nGwalior, Madhya Pradesh-474 005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.aihch.2020.01.001","volume":"132","author":"Ghobadi N.","year":"2020","unstructured":"Ghobadi N.; Nazari N.; Gholamzadeh P.; The Friedl&#xE4;nder reaction:A powerful strategy for the synthesis of heterocycles. Adv Heterocycl Chem 2020,132,85-134","journal-title":"Adv Heterocycl Chem"},{"key":"ref=2","first-page":"365","volume":"13","author":"Orhan P&#xFC;sk&#xFC;ll&#xFC; M.","year":"2013","unstructured":"Orhan P&#xFC;sk&#xFC;ll&#xFC; M.; Tekiner B.; Suzen S.; Recent studies of antioxidant quinoline derivatives. Mini Rev Med Chem 2013,13(3),365-372","journal-title":"Mini Rev Med Chem"},{"key":"ref=3","first-page":"52","volume":"15","author":"Ahmed A.","year":"2012","unstructured":"Ahmed A.; Daneshtalab M.; Nonclassical biological activities of quinolone derivatives. J Pharm Pharm Sci 2012,15(1),52-72","journal-title":"J Pharm Pharm Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1021\/cr60095a007","volume":"30","author":"Manske R.H.","year":"1942","unstructured":"Manske R.H.; The chemistry of isoquinolines. Chem Rev 1942,30(1),145-158","journal-title":"Chem Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1021\/jo952103j","volume":"61","author":"Larsen R.D.","year":"1996","unstructured":"Larsen R.D.; Corley E.G.; King A.O.; Carroll J.D.; Davis P.; Verhoeven T.R.; Reider P.J.; Labelle M.; Gauthier J.Y.; Xiang Y.B.; Zamboni R.J.; Practical route to a new class of LTD4 receptor antagonists. J Org Chem 1996,61(10),3398-3405","journal-title":"J Org Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0223-5234(00)01175-2","volume":"35","author":"Roma G.","year":"2000","unstructured":"Roma G.; Di M.; Grossi G.; Mattioli F.; Ghia M.; 1,8-Naphthyridines IV. 9-Substituted N, N-dialkyl-5-(alkylamino or compounds with anti-aggressive and potent anti-inflammatory activities. Eur J Med Chem 2000,35,1021-1035","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1021\/jm0100335","volume":"44","author":"Chen Y.L.","year":"2001","unstructured":"Chen Y.L.; Fang K.C.; Sheu J.Y.; Hsu S.L.; Tzeng C.C.; Synthesis and antibacterial evaluation of certain quinolone derivatives. J Med Chem 2001,44(14),2374-2377","journal-title":"J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1021\/ol006321x","volume":"2","author":"Kauffman G.S.","year":"2000","unstructured":"Kauffman G.S.; Harris G.D.; Dorow R.L.; Stone B.R.P.; Parsons R.L.; Pesti J.A.; Magnus N.A.; Fortunak J.M.; Confalone P.N.; Nugent W.A.; An efficient chiral moderator prepared from inexpensive (+)-3-carene: Synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963. Org Lett 2000,2(20),3119-3121","journal-title":"Org Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.2174\/138955709791012247","volume":"9","author":"Kumar S.","year":"2009","unstructured":"Kumar S.; Bawa S.; Gupta H.; Biological activities of quinoline derivatives. Mini Rev Med Chem 2009,9(14),1648-1654","journal-title":"Mini Rev Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1016\/S0968-0896(03)00439-5","volume":"11","author":"Chen Y.L.","year":"2003","unstructured":"Chen Y.L.; Chen I.L.; Lu C.M.; Tzeng C.C.; Tsao L.T.; Wang J.P.; Synthesis and anti-inflammatory evaluation of 9-phenoxyacridine and 4-phenoxyfuro[2,3-b]quinoline derivatives. Part 2. Bioorg Med Chem 2003,11(18),3921-3927","journal-title":"Bioorg Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0960-894X(02)00173-7","volume":"12","author":"Park B.S.","year":"2002","unstructured":"Park B.S.; Kim D.Y.; Rosenthal P.J.; Huh S.C.; Lee B.J.; Park E.J.; Kim S.M.; Kim J.E.; Kim M.H.; Huh T.L.; Choi Y.J.; Suh K.H.; Choi W.S.; Lee S.E.; Synthesis and evaluation of new antimalarial analogues of quinoline alkaloids derived from Cinchona ledgeriana moens ex trimen. Bioorg Med Chem Lett 2002,12(10),1351-1355","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1351\/pac199062071303","volume":"62","author":"Vlahov R.","year":"1990","unstructured":"Vlahov R.; Parushev S.; Vlahov J.; Nickel P.; Snatzke G.; Synthesis of some new quinoline derivatives - potential antimalarial drugs. Pure Appl Chem 1990,62(7),1303-1306","journal-title":"Pure Appl Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1021\/jm00367a019","volume":"27","author":"Scovill J.P.","year":"1984","unstructured":"Scovill J.P.; Klayman D.L.; Lambros C.; Childs G.E.; Notsch J.D.; 2-Acetylpyridine thiosemicarbazones. 9. Derivatives of 2-acetylpyridine 1-oxide as potential antimalarial agents. J Med Chem 1984,27(1),87-91","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1021\/jm0400193","volume":"47","author":"Catoen-Chackal S.","year":"2004","unstructured":"Catoen-Chackal S.; Facompr&#xE9; M.; Houssin R.; Pommery N.; Goossens J.F.; Colson P.; Bailly C.; H&#xE9;nichart J.P.; DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents. J Med Chem 2004,47(14),3665-3673","journal-title":"J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/jm00213a024","volume":"20","author":"Antonini I.","year":"1977","unstructured":"Antonini I.; Claudi F.; Franchetti P.; Grifantini M.; Martelli S.; Elucidation of the structure of the antineoplastic agents, 2-formylpyridine and 1-formylisoquinoline thiosemicarbazones. J Med Chem 1977,20(3),447-449","journal-title":"J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1039\/b009171p","volume":"127","author":"Antolovich M.","year":"2002","unstructured":"Antolovich M.; Prenzler P.D.; Patsalides E.; McDonald S.; Robards K.; Methods for testing antioxidant activity. Analyst (Lond) 2002,127(1),183-198","journal-title":"Analyst (Lond)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3329\/bmrcb.v35i2.2564","volume":"35","author":"Hossain M.M.","year":"2009","unstructured":"Hossain M.M.; Shaha S.K.; Aziz F.; Antioxidant potential study of some synthesized N-heterocycles. Bangladesh Med Res Counc Bull 2009,35(2),49-52","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0968-0896(02)00046-9","volume":"10","author":"Sahu N.","year":"2002","unstructured":"Sahu N.; Pal C.; Mandal N.B.; Banerjee S.; Raha M.; Kundu A.P.; Basu A.; Ghosh M.; Roy K.; Bandyopadhyay S.; Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide\u2014a potential antileishmanial agent. Bioorg Med Chem 2002,10(6),1687-1693","journal-title":"Bioorg Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1016\/j.bmcl.2005.07.051","volume":"15","author":"Xie Z.F.","year":"2005","unstructured":"Xie Z.F.; Chai K.Y.; Piao H.R.; Kwak K.C.; Quan Z.S.; Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines. Bioorg Med Chem Lett 2005,15(21),4803-4805","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ejmech.2007.01.004","volume":"42","author":"Nandhakumar R.","year":"2007","unstructured":"Nandhakumar R.; Suresh T.; Jude A.L.C.; Rajesh kannan V; Mohan P.S.; Synthesis, antimicrobial activities and cytogenetic studies of newer diazepino quinoline derivatives via Vilsmeier\u2013Haack reaction. Eur J Med Chem 2007,42(8),1128-1136","journal-title":"Eur J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/molecules13112880","volume":"13","author":"Al-Hiari Y.","year":"2008","unstructured":"Al-Hiari Y.; Abu-Dahab R.; El-Abadelah M.; Heterocycles [h]-fused onto 4-oxoquinoline-3-carboxylic acid, part VIII [1]. Convenient synthesis and antimicrobial properties of substituted hexahydro[1,4]diazepino[2,3-h]quinoline-9-carboxylic acid and its tetrahydroqui-no[7,8-b]benzodiazepine analog. Molecules 2008,13(11),2880-2893","journal-title":"Molecules"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0223-5234(02)01355-7","volume":"37","author":"Ferlin M.G.","year":"2002","unstructured":"Ferlin M.G.; Chiarelotto G.; Antonucci F.; Caparrotta L.; Froldi G.; Mannich bases of 3H-pyrrolo[3,2-f]quinoline having vasorelaxing activity. Eur J Med Chem 2002,37(5),427-434","journal-title":"Eur J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0960-894X(98)00201-7","volume":"8","author":"Dub&#xE9; D.","year":"1998","unstructured":"Dub&#xE9; D.; Blouin M.; Brideau C.; Chan C.C.; Desmarais S.; Ethier D.; Falgueyret J.P.; Friesen R.W.; Girard M.; Girard Y.; Guay J.; Riendeau D.; Tagari P.; Young R.N.; Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530. Bioorg Med Chem Lett 1998,8(10),1255-1260","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1021\/jm00040a003","volume":"37","author":"Maguire M.P.","year":"1994","unstructured":"Maguire M.P.; Sheets K.R.; McVety K.; Spada A.P.; Zilberstein A.; A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J Med Chem 1994,37(14),2129-2137","journal-title":"J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.bmcl.2004.03.005","volume":"14","author":"B&#xE9;nard C.","year":"2004","unstructured":"B&#xE9;nard C.; Zouhiri F.; Normand-Bayle M.; Danet M.; Desma&#xEB;le D.; Leh H.; Mouscadet J.F.; Mbemba G.; Thomas C.M.; Bonnenfant S.; Le Bret M.; d\u2019Angelo J.; Linker-modified quinoline derivatives targeting HIV-1 integrase: Synthesis and biological activity. Bioorg Med Chem Lett 2004,14(10),2473-2476","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=26","first-page":"11","volume":"7","author":"Pathak D.","year":"2016","unstructured":"Pathak D.; Singh D.; Quinoline: A diverse therapeutic agent. Int J Pharm Sci Res 2016,7(1),11-13","journal-title":"Int J Pharm Sci Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1021\/jm980043e","volume":"41","author":"Mekouar K.","year":"1998","unstructured":"Mekouar K.; Mouscadet J.F.; Desma&#xEB;le D.; Subra F.; Leh H.; Savour&#xE9; D.; Auclair C.; d\u2019Angelo J.; Styrylquinoline derivatives: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. J Med Chem 1998,41(15),2846-2857","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nrd1660","volume":"4","author":"Pommier Y.","year":"2005","unstructured":"Pommier Y.; Johnson A.A.; Marchand C.; Integrase inhibitors to treat HIV\/Aids. Nat Rev Drug Discov 2005,4(3),236-248","journal-title":"Nat Rev Drug Discov"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1248\/cpb.55.894","volume":"55","author":"Letafat B.","year":"2007","unstructured":"Letafat B.; Emami S.; Mohammadhosseini N.; Faramarzi M.A.; Samadi N.; Shafiee A.; Foroumadi A.; Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl)ethyl] piperazinyl quinolones. Chem Pharm Bull (Tokyo) 2007,55(6),894-898","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.bmcl.2007.01.038","volume":"17","author":"Srivastava B.K.","year":"2007","unstructured":"Srivastava B.K.; Solanki M.; Mishra B.; Soni R.; Jayadev S.; Valani D.; Jain M.; Patel P.R.; Synthesis and antibacterial activity of 4,5,6,7-tetrahydro-thieno[3,2-c]pyridine quinolones. Bioorg Med Chem Lett 2007,17(7),1924-1929","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev.bi.54.070185.003313","volume":"54","author":"Wang J.C.","year":"1985","unstructured":"Wang J.C.; DNA topoisomerases. Annu Rev Biochem 1985,54(1),665-697","journal-title":"Annu Rev Biochem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/jac\/dkn136","volume":"62","author":"Okumura R.","year":"2008","unstructured":"Okumura R.; Hirata T.; Onodera Y.; Hoshino K.; Otani T.; Yamamoto T.; Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: Contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2008,62(1),98-104","journal-title":"J Antimicrob Chemother"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00044-008-9092-5","volume":"17","author":"Narayan Acharya B.","year":"2008","unstructured":"Narayan Acharya B.; Thavaselvam D.; Parshad Kaushik M.; Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids. Med Chem Res 2008,17(8),487-494","journal-title":"Med Chem Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1023\/B:JCAM.0000004622.13865.4f","volume":"17","author":"Assefa H.","year":"2003","unstructured":"Assefa H.; Kamath S.; Buolamwini J.K.; 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. J Comput Aided Mol Des 2003,17(8),475-493","journal-title":"J Comput Aided Mol Des"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1021\/jm9509408","volume":"39","author":"Baba A.","year":"1996","unstructured":"Baba A.; Kawamura N.; Makino H.; Ohta Y.; Taketomi S.; Sohda T.; Studies on disease-modifying antirheumatic drugs: Synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect. J Med Chem 1996,39(26),5176-5182","journal-title":"J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1021\/jm100329q","volume":"53","author":"Fern&#xE1;ndez-Bachiller M.I.","year":"2010","unstructured":"Fern&#xE1;ndez-Bachiller M.I.; P&#xE9;rez C.; Gonz&#xE1;lez-Mu&#xF1;oz G.C.; Conde S.; L&#xF3;pez M.G.; Villarroya M.; Garc&#xED;a A.G.; Rodr&#xED;guez-Franco M.I.; Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J Med Chem 2010,53(13),4927-4937","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/med.21703","volume":"40","author":"Shang X.F.","year":"2020","unstructured":"Shang X.F.; Yang C.J.; Morris-Natschke S.L.; Li J.C.; Yin X.D.; Liu Y.Q.; Guo X.; Peng J.W.; Goto M.; Zhang J.Y.; Lee K.H.; Biologically active isoquinoline alkaloids covering 2014\u20132018. Med Res Rev 2020,40(6),2212-2289","journal-title":"Med Res Rev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3390\/molecules26113374","volume":"26","author":"Bhambhani S.","year":"2021","unstructured":"Bhambhani S.; Kondhare K.R.; Giri A.P.; Diversity in chemical structures and biological properties of plant alkaloids. Molecules 2021,26(11),3374","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"24463","DOI":"10.1039\/C4RA01814A","volume":"4","author":"Prajapati S.M.","year":"2014","unstructured":"Prajapati S.M.; Patel K.D.; Vekariya R.H.; Panchal S.N.; Patel H.D.; Recent advances in the synthesis of quinolines: A review. RSC Advances 2014,4(47),24463-24476","journal-title":"RSC Advances"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1002\/anie.200200569","volume":"42","author":"Wiesner J.","year":"2003","unstructured":"Wiesner J.; Ortmann R.; Jomaa H.; Schlitzer M.; New antimalarial drugs. Angew Chem Int Ed 2003,42(43),5274-5293","journal-title":"Angew Chem Int Ed"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9336","DOI":"10.1039\/C5OB01379H","volume":"13","author":"Kshirsagar U.A.","year":"2015","unstructured":"Kshirsagar U.A.; Recent developments in the chemistry of quinazolinone alkaloids. Org Biomol Chem 2015,13(36),9336-9352","journal-title":"Org Biomol Chem"},{"key":"ref=42","first-page":"24","author":"Armarego W.L.","year":"2009","unstructured":"Armarego W.L.;  Fused Pyrimidines, Part 1 2009,24","journal-title":"Fused Pyrimidines, Part 1"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejmech.2014.02.005","volume":"76","author":"Khan I.","year":"2014","unstructured":"Khan I.; Ibrar A.; Abbas N.; Saeed A.; Recent advances in the structural library of functionalized quinazoline and quinazolinone scaf-folds: Synthetic approaches and multifarious applications. Eur J Med Chem 2014,76,193-244","journal-title":"Eur J Med Chem"},{"key":"ref=44","first-page":"159","author":"Johne S.","year":"1984","unstructured":"Johne S.; The quinazoline alkaloids. Fortschritte der Chemieorganischer Naturstoffe. Prog Chem Org Nat Prod 1984,159-229","journal-title":"Prog Chem Org Nat Prod"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1-5","DOI":"10.1002\/14356007.a22_465","volume":"31","author":"Collin G.","year":"2000","unstructured":"Collin G.; H&#xF6;ke H.; Quinoline and isoquinoline. Ullmann\u2019s Encyclopedia of Industrial Chemistry 2000,31,1-5","journal-title":"Ullmann\u2019s Encyclopedia of Industrial Chemistry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/jm0010670","volume":"44","author":"Anzali S.","year":"2001","unstructured":"Anzali S.; Barnickel G.; Cezanne B.; Krug M.; Filimonov D.; Poroikov V.; Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). J Med Chem 2001,44(15),2432-2437","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/0976-500X.77119","volume":"2","year":"2011","unstructured":"S, P. Prediction of activity spectra for substances. J Pharmacol Pharmacother 2011,2(1),52-53","journal-title":"J Pharmacol Pharmacother"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jfluchem.2009.01.002","volume":"130","author":"Wang L.M.","year":"2009","unstructured":"Wang L.M.; Hu L.; Chen H.J.; Sui Y.Y.; Shen W.; One-pot synthesis of quinoline-4-carboxylic acid derivatives in water: Ytterbium perfluorooctanoate catalyzed Doebner reaction. J Fluor Chem 2009,130(4),406-409","journal-title":"J Fluor Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10562-007-9127-4","volume":"117","author":"Heged&#xFC;s A.","year":"2007","unstructured":"Heged&#xFC;s A.; Hell Z.; Vargadi T.; Potor A.; Gresits I.; A new, simple synthesis of 1,2-dihydroquinolines via cyclocondensation using zeolite catalyst. Catal Lett 2007,117(3-4),99-101","journal-title":"Catal Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/157017808783330261","volume":"5","author":"Zhou T.","year":"2008","unstructured":"Zhou T.; Lin J.L.; Chen Z.C.; A convenient synthesis of quinolines via ionic liquid-catalysed friedlander annulation. Lett Org Chem 2008,5(1),47-50","journal-title":"Lett Org Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.tetlet.2008.09.097","volume":"50","author":"Ghassamipour S.","year":"2009","unstructured":"Ghassamipour S.; Sardarian A.R.; Friedl&#xE4;nder synthesis of poly-substituted quinolines in the presence of dodecylphosphonic acid (DPA) as a highly efficient, recyclable and novel catalyst in aqueous media and solvent-free conditions. Tetrahedron Lett 2009,50(5),514-519","journal-title":"Tetrahedron Lett"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"103406","DOI":"10.1016\/j.bioorg.2019.103406","volume":"94","author":"Katariya K.D.","year":"2020","unstructured":"Katariya K.D.; Shah S.R.; Reddy D.; Anticancer, antimicrobial activities of quinoline based hydrazone analogues: Synthesis, characterization and molecular docking. Bioorg Chem 2020,94,103406","journal-title":"Bioorg Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.tet.2008.12.039","volume":"65","author":"Qi C.","year":"2009","unstructured":"Qi C.; Zheng Q.; Hua R.; A domino three-component condensation of ortho-haloacetophenones with urea or amines: A novel one-pot synthesis of halogen-substituted quinolines. Tetrahedron 2009,65(7),1316-1320","journal-title":"Tetrahedron"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1055\/s-0030-1259065","volume":"2010","author":"Mohammadpoor-Baltork I.","year":"2010","unstructured":"Mohammadpoor-Baltork I.; Tangestaninejad S.; Moghadam M.; Mirkhani V.; Anvar S.; Mirjafari A.; Microwave-promoted alkynylation-cyclization of 2-aminoaryl ketones: A green strategy for the synthesis of 2,4-disubstituted quinolines. Synlett 2010,2010(20),3104-3112","journal-title":"Synlett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ultsonch.2010.07.020","volume":"18","author":"Kowsari E.","year":"2011","unstructured":"Kowsari E.; Mallakmohammadi M.; Ultrasound promoted synthesis of quinolines using basic ionic liquids in aqueous media as a green procedure. Ultrason Sonochem 2011,18(1),447-454","journal-title":"Ultrason Sonochem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1021\/jo1017525","volume":"75","author":"Zhao J.","year":"2010","unstructured":"Zhao J.; Peng C.; Liu L.; Wang Y.; Zhu Q.; Synthesis of 2-alkoxy(aroxy)-3-substituted quinolines by DABCO-promoted cyclization of o-alkynylaryl isocyanides. J Org Chem 2010,75(21),7502-7504","journal-title":"J Org Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1055\/s-0028-1087340","volume":"2008","author":"Prajapati D.","year":"2008","unstructured":"Prajapati D.; Sarma R.; Ionic liquid - An efficient recyclable system for the synthesis of 2,4-disubstituted quinolines via Meyer-Schuster rearrangement. Synlett 2008,2008(19),3001-3005","journal-title":"Synlett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1021\/jm101340q","volume":"54","author":"Wang Y.","year":"2011","unstructured":"Wang Y.; Ai J.; Wang Y.; Chen Y.; Wang L.; Liu G.; Geng M.; Zhang A.; Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: Identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a novel anticancer agent. J Med Chem 2011,54(7),2127-2142","journal-title":"J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"9778","DOI":"10.1021\/jo801678n","volume":"73","author":"Mart&#xED;nez R.","year":"2008","unstructured":"Mart&#xED;nez R.; Ram&#xF3;n D.J.; Yus M.; Transition-metal-free indirect friedlander synthesis of quinolines from alcohols. J Org Chem 2008,73(24),9778-9780","journal-title":"J Org Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1016\/j.bmc.2006.02.039","volume":"14","author":"Chen Y.L.","year":"2006","unstructured":"Chen Y.L.; Zhao Y.L.; Lu C.M.; Tzeng C.C.; Wang J.P.; Synthesis, cytotoxicity, and anti-inflammatory evaluation of 2-(furan-2-yl)-4-(phenoxy)quinoline derivatives. Part 4. Bioorg Med Chem 2006,14(13),4373-4378","journal-title":"Bioorg Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1021\/ol8016726","volume":"10","author":"Horn J.","year":"2008","unstructured":"Horn J.; Marsden S.P.; Nelson A.; House D.; Weingarten G.G.; Convergent, regiospecific synthesis of quinolines from o-aminophenylboronates. Org Lett 2008,10(18),4117-4120","journal-title":"Org Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/jo9026116","volume":"75","author":"Gao G.L.","year":"2010","unstructured":"Gao G.L.; Niu Y.N.; Yan Z.Y.; Wang H.L.; Wang G.W.; Shaukat A.; Liang Y.M.; Unexpected domino reaction via Pd-catalyzed Sonogashira coupling of benzimidoyl chlorides with 1,6-enynes and cyclization to synthesize quinoline derivatives. J Org Chem 2010,75(4),1305-1308","journal-title":"J Org Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1021\/jo902603v","volume":"75","author":"Huo Z.","year":"2010","unstructured":"Huo Z.; Gridnev I.D.; Yamamoto Y.; A method for the synthesis of substituted quinolines via electrophilic cyclization of 1-azido-2-(2-propynyl)benzene. J Org Chem 2010,75(4),1266-1270","journal-title":"J Org Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"104639","DOI":"10.1016\/j.bioorg.2021.104639","volume":"109","author":"Yadav P.","year":"2021","unstructured":"Yadav P.; Shah K.; Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry. Bioorg Chem 2021,109,104639","journal-title":"Bioorg Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1016\/j.bmc.2009.08.003","volume":"17","author":"Iwaniuk D.P.","year":"2009","unstructured":"Iwaniuk D.P.; Whetmore E.D.; Rosa N.; Ekoue-Kovi K.; Alumasa J.; de Dios A.C.; Roepe P.D.; Wolf C.; Synthesis and antimalarial activity of new chloroquine analogues carrying a multifunctional linear side chain. Bioorg Med Chem 2009,17(18),6560-6566","journal-title":"Bioorg Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0006-2952(96)00306-1","volume":"52","author":"Raynes K.","year":"1996","unstructured":"Raynes K.; Foley M.; Tilley L.; Deady L.W.; Novel bisquinoline antimalarials. Biochem Pharmacol 1996,52(4),551-559","journal-title":"Biochem Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1016\/j.bmcl.2007.07.049","volume":"17","author":"Mahajan A.","year":"2007","unstructured":"Mahajan A.; Yeh S.; Nell M.; van Rensburg C.E.J.; Chibale K.; Synthesis of new 7-chloroquinolinyl thioureas and their biological investigation as potential antimalarial and anticancer agents. Bioorg Med Chem Lett 2007,17(20),5683-5685","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1021\/jm100911f","volume":"54","author":"Shiraki H.","year":"2011","unstructured":"Shiraki H.; Kozar M.P.; Melendez V.; Hudson T.H.; Ohrt C.; Magill A.J.; Lin A.J.; Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. J Med Chem 2011,54(1),131-142","journal-title":"J Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00044-010-9397-z","volume":"20","author":"Singh B.","year":"2011","unstructured":"Singh B.; Chetia D.; Puri S.K.; Srivastava K.; Prakash A.; Synthesis and in vitro and in vivo antimalarial activity of novel 4-anilinoquinoline Mannich base derivatives. Med Chem Res 2011,20(9),1523-1529","journal-title":"Med Chem Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1016\/j.bmc.2005.05.053","volume":"13","author":"Abadi A.H.","year":"2005","unstructured":"Abadi A.H.; Hegazy G.H.; El-Zaher A.A.; Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and antiinflammatory agents. Bioorg Med Chem 2005,13(20),5759-5765","journal-title":"Bioorg Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1016\/j.bmcl.2008.10.065","volume":"18","author":"Gilbert A.M.","year":"2008","unstructured":"Gilbert A.M.; Bursavich M.G.; Lombardi S.; Georgiadis K.E.; Reifenberg E.; Flannery C.R.; Morris E.A.; N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy\/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2). Bioorg Med Chem Lett 2008,18(24),6454-6457","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00044-010-9522-z","volume":"21","author":"Marganakop S.B.","year":"2012","unstructured":"Marganakop S.B.; Kamble R.R.; Taj T.; Kariduraganvar M.Y.; An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti tubercular agents. Med Chem Res 2012,21(2),185-191","journal-title":"Med Chem Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bmcl.2008.12.046","volume":"19","author":"Scott D.A.","year":"2009","unstructured":"Scott D.A.; Balliet C.L.; Cook D.J.; Davies A.M.; Gero T.W.; Omer C.A.; Poondru S.; Theoclitou M.E.; Tyurin B.; Zinda M.J.; Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase. Bioorg Med Chem Lett 2009,19(3),697-700","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.bmcl.2008.12.097","volume":"19","author":"Mai A.","year":"2009","unstructured":"Mai A.; Rotili D.; Tarantino D.; Nebbioso A.; Castellano S.; Sbardella G.; Tini M.; Altucci L.; Identification of 4-hydroxyquinolines inhibitors of p300\/CBP histone acetyltransferases. Bioorg Med Chem Lett 2009,19(4),1132-1135","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bmcl.2008.11.037","volume":"19","author":"Miller L.M.","year":"2009","unstructured":"Miller L.M.; Mayer S.C.; Berger D.M.; Boschelli D.H.; Boschelli F.; Di L.; Du X.; Dutia M.; Floyd M.B.; Johnson M.; Kenny C.H.; Krishnamurthy G.; Moy F.; Petusky S.; Tkach D.; Torres N.; Wu B.; Xu W.; Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorg Med Chem Lett 2009,19(1),62-66","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.bmcl.2008.11.078","volume":"19","author":"Ma X.","year":"2009","unstructured":"Ma X.; Zhou W.; Brun R.; Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones. Bioorg Med Chem Lett 2009,19(3),986-989","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1016\/j.bmc.2009.02.026","volume":"17","author":"Upadhayaya R.S.","year":"2009","unstructured":"Upadhayaya R.S.; Vandavasi J.K.; Vasireddy N.R.; Sharma V.; Dixit S.S.; Chattopadhyaya J.; Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis. Bioorg Med Chem 2009,17(7),2830-2841","journal-title":"Bioorg Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","volume":"17","author":"de Souza M.V.N.","year":"2009","unstructured":"de Souza M.V.N.; Pais K.C.; Kaiser C.R.; Peralta M.A.; de L Ferreira, M.; Louren&#xE7;o, M.C. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg Med Chem 2009,17(4),1474-1480","journal-title":"Bioorg Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1021\/jm900003c","volume":"52","author":"Lilienkampf A.","year":"2009","unstructured":"Lilienkampf A.; Mao J.; Wan B.; Wang Y.; Franzblau S.G.; Kozikowski A.P.; Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. J Med Chem 2009,52(7),2109-2118","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1016\/j.ejmech.2010.04.022","volume":"45","author":"Eswaran S.","year":"2010","unstructured":"Eswaran S.; Adhikari A.V.; Chowdhury I.H.; Pal N.K.; Thomas K.D.; New quinoline derivatives: Synthesis and investigation of antibacterial and antituberculosis properties. Eur J Med Chem 2010,45(8),3374-3383","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1016\/j.bmc.2007.08.009","volume":"15","author":"Gholap A.R.","year":"2007","unstructured":"Gholap A.R.; Toti K.S.; Shirazi F.; Kumari R.; Bhat M.K.; Deshpande M.V.; Srinivasan K.V.; Synthesis and evaluation of antifungal properties of a series of the novel 2-amino-5-oxo-4-phenyl-5,6,7,8-tetrahydroquinoline-3-carbonitrile and its analogues. Bioorg Med Chem 2007,15(21),6705-6715","journal-title":"Bioorg Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s00044-010-9463-6","volume":"20","author":"Kumar S.","year":"2011","unstructured":"Kumar S.; Bawa S.; Drabu S.; Panda B.P.; Design and synthesis of 2-chloroquinoline derivatives as non-azoles antimycotic agents. Med Chem Res 2011,20(8),1340-1348","journal-title":"Med Chem Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00044-008-9138-8","volume":"18","author":"Kharkar P.S.","year":"2009","unstructured":"Kharkar P.S.; Deodhar M.N.; Kulkarni V.M.; Design, synthesis, antifungal activity, and ADME prediction of functional analogues of terbinafine. Med Chem Res 2009,18(6),421-432","journal-title":"Med Chem Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"105117","DOI":"10.1016\/j.bioorg.2021.105117","volume":"114","author":"Seliem I.A.","year":"2021","unstructured":"Seliem I.A.; Panda S.S.; Girgis A.S.; Moatasim Y.; Kandeil A.; Mostafa A.; Ali M.A.; Nossier E.S.; Rasslan F.; Srour A.M.; Sakhuja R.; Ibrahim T.S.; Abdel-samii Z.K.M.; Al-Mahmoudy A.M.M.; New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2. Bioorg Chem 2021,114,105117","journal-title":"Bioorg Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijantimicag.2008.05.001","volume":"32","author":"Ghosh J.","year":"2008","unstructured":"Ghosh J.; Swarup V.; Saxena A.; Das S.; Hazra A.; Paira P.; Banerjee S.; Mondal N.B.; Basu A.; Therapeutic effect of a novel anilidoquinoline derivative, 2-(2-methyl-quinoline-4ylamino)-N-(2-chlorophenyl)-acetamide, in Japanese encephalitis: Correlation with in vitro neuroprotection. Int J Antimicrob Agents 2008,32(4),349-354","journal-title":"Int J Antimicrob Agents"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.bmc.2009.01.038","volume":"17","author":"Chen S.","year":"2009","unstructured":"Chen S.; Chen R.; He M.; Pang R.; Tan Z.; Yang M.; Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat\u2013TAR interaction inhibitors. Bioorg Med Chem 2009,17(5),1948-1956","journal-title":"Bioorg Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.bmc.2003.09.007","volume":"11","author":"Fakhfakh M.A.","year":"2003","unstructured":"Fakhfakh M.A.; Fournet A.; Prina E.; Mouscadet J.F.; Franck X.; Hocquemiller R.; Figad&#xE8;re B.; Synthesis and biological evaluation of substituted quinolines: Potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 2003,11(23),5013-5023","journal-title":"Bioorg Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.22270\/jddt.v12i4.5561","volume":"12","author":"Bharti A.","year":"2022","unstructured":"Bharti A.; Bijauliya R.K.; Yadav A.; Suman ; The chemical and pharmacological advancements of quinoline: A mini review. J Drug Deliv Ther 2022,12(4),211-215","journal-title":"J Drug Deliv Ther"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1016\/j.bmcl.2005.07.044","volume":"15","author":"Rossiter S.","year":"2005","unstructured":"Rossiter S.; P&#xE9;ron J.M.; Whitfield P.J.; Jones K.; Synthesis and anthelmintic properties of arylquinolines with activity against drug-resistant nematodes. Bioorg Med Chem Lett 2005,15(21),4806-4808","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1016\/j.bmc.2007.08.044","volume":"15","author":"Cai Z.","year":"2007","unstructured":"Cai Z.; Zhou W.; Sun L.; Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents. Bioorg Med Chem 2007,15(24),7809-7829","journal-title":"Bioorg Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/1043-6618(90)90729-W","volume":"22","author":"Srimal R.C.","year":"1990","unstructured":"Srimal R.C.; Gulati K.; Nityanand S.; Dhawan B.N.; Pharmacological studies on 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl) quinoline (centhaquin). I. hypotensive activity. Pharmacol Res 1990,22(3),319-329","journal-title":"Pharmacol Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.bmc.2008.12.048","volume":"17","author":"Bernotas R.C.","year":"2009","unstructured":"Bernotas R.C.; Singhaus R.R.; Kaufman D.H.; Ullrich J.; Fletcher H.; Quinet E.; Nambi P.; Unwalla R.; Wilhelmsson A.; Goos-Nilsson A.; Farnegardh M.; Wrobel J.; Biarylether amide quinolines as liver X receptor agonists. Bioorg Med Chem 2009,17(4),1663-1670","journal-title":"Bioorg Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1016\/j.bmc.2007.03.013","volume":"15","author":"Hu B.","year":"2007","unstructured":"Hu B.; Jetter J.; Kaufman D.; Singhaus R.; Bernotas R.; Unwalla R.; Quinet E.; Savio D.; Halpern A.; Basso M.; Keith J.; Clerin V.; Chen L.; Liu Q.Y.; Feingold I.; Huselton C.; Azam F.; Goos-Nilsson A.; Wilhelmsson A.; Nambi P.; Wrobel J.; Further modification on phenyl acetic acid based quinolines as liver X receptor modulators. Bioorg Med Chem 2007,15(10),3321-3333","journal-title":"Bioorg Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.bmcl.2008.12.005","volume":"19","author":"Smith P.W.","year":"2009","unstructured":"Smith P.W.; Wyman P.A.; Lovell P.; Goodacre C.; Serafinowska H.T.; Vong A.; Harrington F.; Flynn S.; Bradley D.M.; Porter R.; Coggon S.; Murkitt G.; Searle K.; Thomas D.R.; Watson J.M.; Martin W.; Wu Z.; Dawson L.A.; New quinoline NK3 receptor antagonists with CNS activity. Bioorg Med Chem Lett 2009,19(3),837-840","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0960-894X(00)00354-1","volume":"10","author":"Edmont D.","year":"2000","unstructured":"Edmont D.; Rocher R.; Plisson C.; Chenault J.; Synthesis and evaluation of quinoline carboxyguanidines as antidiabetic agents. Bioorg Med Chem Lett 2000,10(16),1831-1834","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bmcl.2009.01.045","volume":"19","author":"Lunniss C.J.","year":"2009","unstructured":"Lunniss C.J.; Cooper A.W.J.; Eldred C.D.; Kranz M.; Lindvall M.; Lucas F.S.; Neu M.; Preston A.G.S.; Ranshaw L.E.; Redgrave A.J.; Ed Robinson J.; Shipley T.J.; Solanke Y.E.; Somers D.O.; Wiseman J.O.; Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration. Bioorg Med Chem Lett 2009,19(5),1380-1385","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1021\/jm101501b","volume":"54","author":"Wolkenberg S.E.","year":"2011","unstructured":"Wolkenberg S.E.; Zhao Z.; Thut C.; Maxwell J.W.; McDonald T.P.; Kinose F.; Reilly M.; Lindsley C.W.; Hartman G.D.; Design, synthesis, and evaluation of novel 3,6-diaryl-4-aminoalkoxyquinolines as selective agonists of somatostatin receptor subtype 2. J Med Chem 2011,54(7),2351-2358","journal-title":"J Med Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.bmcl.2003.12.090","volume":"14","author":"Bi Y.","year":"2004","unstructured":"Bi Y.; Stoy P.; Adam L.; He B.; Krupinski J.; Normandin D.; Pongrac R.; Seliger L.; Watson A.; Macor J.E.; Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction. Bioorg Med Chem Lett 2004,14(6),1577-1580","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2000291","DOI":"10.1002\/ardp.202000291","author":"Bazine I.","year":"2020","unstructured":"Bazine I.; Bendjedid S.; Boukhari A.; Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety. Arch Pharm 2020,2000291","journal-title":"Arch Pharm"},{"key":"ref=100","first-page":"41","volume":"45","author":"Rathod S.V.","year":"2021","unstructured":"Rathod S.V.; Shinde K.W.; Kharkar P.S.; Shah C.P.; Synthesis, molecular docking, and biological evaluation of novel 2-(3-chlorophenyl)quinoline-4-carboxamide derivatives as potent anti breast cancer and antibacterial agents. Thaiphesatchasan 2021,45,41-49","journal-title":"Thaiphesatchasan"}],"container-title":["Current Organic Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570179420666221004143910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209540\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570179420666221004143910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T16:42:09Z","timestamp":1691426529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209540\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570179420666221004143910","relation":{},"ISSN":["1570-1794"],"issn-type":[{"value":"1570-1794","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}